SMOORE
SMOORE, the world's largest vaping manufacturer, today launches the world’s thinnest ceramic coil vape pod solution - FEELM Air at its New Technology Launch Event in London. FEELM Air features 7 major breakthroughs in vaping experience, including ultimate design, reliability, flavor and joyful interactive experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220118005508/en/
The comprehensive improvement of FEELM Air is attributed to the new generation of Ultra-slim Bionic Film Ceramic Coil, which is created with 3 revolutionary innovations.
3 Innovations on Ultra-slim Bionic Film Ceramic Coil
Firstly, it has the world's first 7-layer composite heating film made of bionic material, with each layer leading to a correspondingly enhanced functionality.
Secondly, the new bionic ceramic coil leverages Nanoscale Vacuumed Film-forming Technique to make the heating film distributed more evenly, for accurate temperature distribution.
Thirdly, it features a microporous bionic structure to provide smooth ventilation as well as strong leakage-proof performance.
7 Breakthroughs in vaping experience brought by FEELM Air
Underpinned by Ultra-slim Bionic Film Ceramic Coil, FEELM Air manages to achieve 7 major breakthroughs.
Most importantly, FEELM Air improves an overall harm reduction performance by 80%, compared with last generation. Hybrid Composites Heating Layer and the industry's first Nanoscale Protection Layer with corrosion resistance reduce the emission of heavy metals by 78.6%; and Temperature Control Layer with thermal conductivity can reduce the emission of Aldehydes and Ketones by 80.7% due to localized over-heating, compared with last generation.
The second breakthrough is more authentic flavor reproduction. FEELM Air employs the exclusive and patented Flavor-Lock™ technology, which improves average flavor release by 33%. Moreover, terraced temperature zone and multi-layered atomization of the ceramic coil allow tailored flavor release in different temperature zones. Microporous Flavor-Lock™ Layer produces aerosols in smaller particle size for consumers to taste the flavor thoroughly.
Thirdly, FEELM Air features an excellent leakage-proof performance. It utilizes 2nd Generation of “Puzzle leakage-proof” technology, decreasing leakage rate by 237%, by means of capillary structure and an innovative choke valve to prevent condensation. Besides, Superabsorbent Lock Layer can effectively prevent e-liquid splashing.
In terms of energy optimization, FEELM Air boasts the world's highest energy efficiency of 1.3mg/W, by virtue of three layers of composite materials. Temperature Control Layer allows the heating film to form a proper terraced temperature zone. Nano Silver Electro Layer can reduce invalid energy consumption while Porous Thermal Resistance Layer can effectively reduce heat loss.
The fifth breakthrough is mounting the world's smallest linear motor, which offers a unique "Shock-wave Mode", bringing users delicate vibrations and interactive vaping experience, so that the user can feel the resonance in every puff. The power consumption of vibrations per charge is as low as 0.06%, which is equal to only two puffs.
Meanwhile, FEELM Air has industry's first super power management system “TOPOWER™”, which allows 10-minute charge for 8-hour vaping. In contrast to the last generation, the system’s energy density is increased by 20% and battery life is increased by 30%.
Finally, FEELM Air adopts an integrated MEMS (Micro-electro Mechanical Systems), which functions as a reliable airflow switch, to improve the sensitivity of the device while preventing mis-activation.
"FEELM Air is an outcome of cross-disciplinary research, and a revolutionary innovation to ceramic coil, " said Frank Han, President of FEELM at opening remark of the launch event. "It upgrades the current single-layer film to a 7-layer biotic thin film. The thickness of the film is reduced from 80 micrometers to 2 micrometers, which is 40 times thinner than the last generation."
FEELM Brand Refresh
In addition, Frank Han announced the brand refresh of FEELM at the launch event. The new brand concept is composed of five words: Feel, Engine, Exploration, Lifestyle and Memory, echoing the five letters of the brand name FEELM. He also unveiled new FEELM logo, which has the contour of ceramic coil and is in a shape of window, symbolizing FEELM’s Window to Ultimate Sensation. The “open window” stands for the infinite pursuit of a better sensory experience, representing FEELM’s commitment to ultimate sensation.
Ever since the launch of the world’s first black ceramic atomization coil with metallic film in 2016, FEELM has changed the whole competitive landscape, ushering in a new era of ceramic coil. It has largely enhanced harm reduction with accurate heating temperature control and revolutionized vaping experience with smooth and pure taste till the last puff. More importantly, FEELM has effectively addressed the industry’s pain points of leakage and dry hit.
By 2022, vaping devices loaded with FEELM atomizers have been exported to over 50 countries in Europe, America, East Asia, Africa, and Oceania, with its accumulated sales volume of over 3 billion pieces. FEELM has never stopped the constant exploration for ultimate sensation. By virtue of FEELM Air, equipped with Ultra-slim Bionic Film Ceramic Coil, FEELM is ready to drive another paradigm shift in the global vaping industry, leading the second sensory revolution of ultra-slim device and ceramic coil.
About FEELM
FEELM tech is a high-quality pod system solution belonging to SMOORE, based on the world's leading ceramic coil heating technology. Combing with flavor reproduction technology and innovative electronics technology and structure design, bringing ultimate sensation and premium vaping experience to global vapers. Focusing on the research of cutting-edge atomization technology, FEELM provides vape brands with total solutions and manufacturing. Now FEELM symbol is on the vape pods of market-leading vaping brands around the world, such as RELX, NJOY, Haka, and VAPO.
About SMOORE
SMOORE is a global leader in offering vaping technology solutions, including manufacturing vaping devices, and vaping components, with advanced R&D technology, strong manufacturing capacity, wide-spectrum product portfolio and diverse customer base. The Company is the world’s largest vaping device manufacturer in terms of revenue, accounting for 18.9% of the total global market share.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220118005508/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis2.6.2025 13:00:00 CEST | Press release
ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effectiveness and safety of monthly IM-101 dosing in relieving complement-induced symptoms in MG. “This IND approval is pivotal for us as it brings us one step closer to delivering a transformative therapy for patients with autoimmune disorders”, said Dr. Dongjo Kim, the CEO of ImmunAbs, “we believe IM-101 has the potential to deliver deeper therapeutic responses and more durable remissions in patients who have failed to achieve sustained remission with current approved treatment.” About Myasthenia Gravis
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”2.6.2025 13:00:00 CEST | Press release
Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies and subject matter experts. Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Lenovo. “Teaming up with Bellevue allows us to attract the right talent using the right technology and deliver on our mission to make ‘smarter technology for all’ a reality.” As a preferred higher education institution tapped to team up with Lenovo to offer supply chain short-term learning, Bellevue will leverage the breadth and depth of Lenovo’s supply chain expe
Lifezone Metals Files Initial Assessment for the Kabanga Nickel Project in Tanzania2.6.2025 12:30:00 CEST | Press release
Vertically Integrated Plan includes Hydrometallurgical Refinery at Kahama $2.37 Billion After-Tax NPV (8%) and 22.9% After-Tax IRR at $8.49 per Pound Nickel Price Initial Assessment Proposes a 22-Year Mine Plan at Average 2.39% Nickel Equivalent Grade Webcast with Technical Leadership Team at 10 AM ET on Tuesday, June 3, 2025 Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery at Kahama. The study covers the Main, MNB, Kima, North, and Tembo zones and is based on the December 2024 Mineral Resource Update (refer to Lifezone’s December 5, 2024 news
Corpay Cross-Border Named an Official Partner of Real Madrid C.F.2.6.2025 12:00:00 CEST | Press release
Providing access to currency risk management and cross-border payments solutions Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into an agreement with Real Madrid C.F. to become an Official Partner. Through this partnership, Real Madrid will be able to gain access to and utilise Corpay Cross Border’s innovative solutions to help mitigate foreign exchange exposure from their day-to-day business needs. "The Corpay Cross-Border team is elated to be named an Official Partner of Real Madrid, one of the world’s most widely recognized and followed sports franchises," said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “With our strong focus on growing the Corpay brand, as well as our currency risk management business, we are excited to partner with one of the most successful football clubs in the world.” About Corpay Corpay, Inc. (NYSE: CPAY) is a global S&P500 corporate payments co
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 20252.6.2025 12:00:00 CEST | Press release
Preliminary results highlight anti-tumor activity and favorable safety profiles of both B7-H4-targeting ADC and CDK2 inhibitorData underscore strength of emerging breast cancer pipeline as part of BeOne’s global transformation with next wave of innovation BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Poster presentations feature preliminary results of the dose escalation studies of two investigational molecules: BG-C9074, a novel B7-H4-targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors, including breast cancer, and BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), in HR+/HER2- breast cancer patients with prior CDK4/6i exposure. “Presenting the first clinical data for two novel breast cancer candidates at ASCO 2025 marks a pivotal moment for BeOne,” said Mark Lanas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom